IP Library Granted Patent US 12,667,594
Granted Patent B2
US 12,667,594 · App. 17/241,412 · Granted Jun 30, 2026

Hyaluronic composition

Inventors: Timothy Ganey (Tampa, FL); Harry Thomas Temple (Miami, FL); Shabnam Namin (Miami, FL)
Assignee: Vivex Biologics Group, Inc.
A61K35/58A61K8/735A61K8/987A61K31/728A61K35/32A61K35/35A61K38/1841A61K38/39A61K47/02A61L27/10A61L27/12A61L27/26A61L27/3608A61L27/3612A61L27/56A61Q17/005A61L2400/06A61L2400/12A61L2430/06A61L2430/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,667,594
App. No.
17/241,412
Filed
Apr 27, 2021
Granted
Jun 30, 2026
Kind
B2
Art Unit
1611
USPC
424/426
Abstract

A composition has hyaluronic acid and one or more materials as an admixture. The hyaluronic acid is derived from a fascia tissue layer of an alligator, the fascia layer located below a hide and above muscle tissue. The one or more materials as the admixture to the hyaluronic acid can be a carrier, diluent or excipient. The hyaluronic acid is extracted from the fascia tissue layer in the form of an oil having an oily viscosity with a molecular weight of 30,000 or greater. The oil extracted includes the hyaluronic acid and includes sodium or salts of hyaluronic acid. The oil extracted is anti-inflammatory to human tissue.

Claims (12)

1 . A composition comprising:

hyaluronic acid obtained from a fascia tissue layer of an alligator, wherein the fascia layer is located below a hide and above muscle tissue, wherein the hyaluronic acid is extracted from the fascia tissue layer in the form of an oil having an oily viscosity with a molecular weight of 30,000 Da or greater, and wherein the extracted oil comprises hyaluronic acid and sodium or salts of hyaluronic acid;

one or more polymer materials as an admixture to the hyaluronic acid and sodium or salts of hyaluronic acid in the oil as a carrier, diluent, or excipient, wherein the hyaluronic acid is infused in the carrier, diluent, or excipient; wherein the carrier is of high porosity exhibiting 50 or greater void volume with a variable pore size of 50 to 1000 microns; wherein the high porosity carrier has a plurality of open cells or pores; wherein some of the open cells or pores are interconnected forming passages through the carrier; wherein some of the open cells or pores are separated by windows, the windows being of a 10 micron thickness or greater; wherein the carrier is an osteoconductive/osteoinductive material for inducing bone growth and repair;

wherein the composition is a hyaluronic acid foam that further comprises micro and nano sized ceramic particles selected from a group consisting of hydroxyapatite, calcium phosphates, silicates, B-TCP tetracalcium phosphate, and calcium carbonate, and combinations thereof; and cartilage particles or cartilage fluff imbued in the foam configured for use in cartilage tissue repair.

2 . The composition of claim 1 , wherein the composition of the hyaluronic acid foam further comprises demineralized bone in the form of fibers and/or particles imbued in the hyaluronic acid foam.

3 . The composition of claim 1 , wherein the composition further comprises acellular biologic materials including exosomes, vesicles, cell fragments, ligands, lipid rafts, organelles, or a combination thereof.

4 . The composition of claim 1 , further comprising TGF-b added to the hyaluronic acid foam.

5 . A composition comprising:

hyaluronic acid obtained from a fascia tissue layer of an alligator, wherein the fascia layer is located below a hide and above muscle tissue, wherein the hyaluronic acid is extracted from the fascia tissue layer in the form of an oil having an oily viscosity with a molecular weight of 30,000 or greater, and wherein the extracted oil comprises the hyaluronic acid and sodium or salts of hyaluronic acid; and

one or more polymer materials as an admixture to the hyaluronic acid and sodium or salts of hyaluronic acid in the oil as a carrier, diluent, or excipient, wherein the one or more polymer materials comprises collagen and amniotic fluid,

wherein the composition is reconstituted as a paste or gel configured for use in for topical cosmetics, skin treatments or wound care or hand sanitization.

6 . The composition of claim 5 , further comprising a non-alcohol based germicidal agent.

Assignments (2)
SECURITY INTEREST Recorded Aug 4, 2022
From: VIVEX BIOLOGICS GROUP, INC.
To: HERITAGE BANK OF COMMERCE
Reel/Frame 061084/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2021
From: GANEY, TIMOTHY; TEMPLE, HARRY THOMAS; NAMIN, SHABNAM
To: VIVEX BIOLOGICS GROUP, INC.
Reel/Frame 056052/0912 →
Continuity (2)
Provisional Application 63019639 · May 4, 2020
Related Publication 20210338742A1 · Nov 4, 2021
References Cited (35)
US 4272522A · Balazs · 1981 [cited by applicant]
US 5128326A · Balazs · 1992 [cited by applicant]
US 5294446A · Schlameus et al. · 1994 [cited by applicant]
US 5356629A · Sander et al. · 1994 [cited by applicant]
US 5925626A · Della Valle · 1999 [cited by applicant]
US 6703377B2 · Radomsky · 2004 [cited by applicant]
US 6723706B2 · Pressato et al. · 2004 [cited by applicant]
US 7691829B2 · Petito · 2010 [cited by examiner]
US 9144631B2 · Asius et al. · 2015 [cited by applicant]
US 9675643B2 · Weston et al. · 2017 [cited by applicant]
US 9687511B2 · Weston et al. · 2017 [cited by applicant]
US 10064896B2 · Temple et al. · 2018 [cited by applicant]
US 10413572B2 · Namin et al. · 2019 [cited by applicant]
US 10645921B2 · Temple et al. · 2020 [cited by applicant]
US 20090175944A1 · Ringeisen · 2009 [cited by examiner]
US 20130052155A1 · Marcolongo · 2013 [cited by examiner]
US 20140335046A1 · Matheny · 2014 [cited by examiner]
US 20180021138A1 · Estes · 2018 [cited by examiner]
US 20200230174A1 · Chung et al. · 2020 [cited by applicant]
US 20210386863A1 · Hahn · 2021 [cited by examiner]
CN 102108318 · 2011 [cited by applicant]
CN 102232578 · 2011 [cited by applicant]
CN 105362470 · 2016 [cited by applicant]
CN 105362471 · 2016 [cited by applicant]
CN 107513461 · 2017 [cited by applicant]
CN 108066288 · 2018 [cited by applicant]
CN 108467779 · 2018 [cited by applicant]
CN 105816358B · 2019 [cited by examiner]
CN 110075356 · 2019 [cited by applicant]
CN 110354055 · 2019 [cited by applicant]
MX 2008009296 · 2010 [cited by applicant]
WO 2021108790A1 · 2021 [cited by applicant]
Gansau J, Buckley CT. Incorporation of Collagen and Hyaluronic Acid to Enhance the Bioactivity of Fibrin-Based Hydrogels for Nucleus Pulposus Regeneration. J Funct Biomater. Jul. 10, 2018;9(3):43. doi: 10.3390/jfb903004… [cited by examiner]
Alligator Byproducts: A Reservoir of Hyaluronic Acid for Biomedical and Cosmetic Applications, Jack Losso and Jose Daniel Estrada-Andino, 2019 issue of Louisiana Agriculture; https://www.lsuagcenter.com/profiles/lbenedi… [cited by applicant]
Louisiana Alligators: From Threatened to Thriving; National Sea Grant NOAA LSU, Jun. 30, 2017; https://www.laseagrant.org/2017/la-alligators-threatened-to-thriving/. [cited by applicant]